Skip to main content
Clinical Trials/NCT03543124
NCT03543124
Active, not recruiting
Not Applicable

Prospective Randomized Control Trial (RCT) of Water Exchange (WE) vs. WE Plus Cap-assisted Colonoscopy

VA Greater Los Angeles Healthcare System2 sites in 1 country256 target enrollmentMay 21, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colonoscopy
Sponsor
VA Greater Los Angeles Healthcare System
Enrollment
256
Locations
2
Primary Endpoint
Real-time maximum insertion pain(RTMIP) score
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

Water exchange (WE) method has been shown to reduce medication requirement and pain experience during the colonoscopy. Cap-assisted colonoscopy aided by air may also reduced the insertion pain. Therefore, the immediate aim of this study is to assess the generalizability of the impact of WE plus cap (WECAC), as a potentially less painful insertion technique than WE. The control group will use water infusion in lieu of air insufflation during insertion of the colonoscope. The study group will added a cap onto the end of colonoscope during the WE method procedure. This study will also demonstrate if the WECAC method have a shorter insertion time and higher proximal colon adenoma detection rate (ADR) than WE alone in Veterans.

Registry
clinicaltrials.gov
Start Date
May 21, 2018
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
VA Greater Los Angeles Healthcare System
Responsible Party
Principal Investigator
Principal Investigator

Felix W. Leung

Site PI and Director of Study

VA Greater Los Angeles Healthcare System

Eligibility Criteria

Inclusion Criteria

  • Informed/educated male and female Veterans undergoing screening, diagnostic or surveillance colonoscopy at participating sites, choosing scheduled unsedated colonoscopy for any reason

Exclusion Criteria

  • Decline to be randomized
  • Unable to give consent or respond to questionnaires
  • History of colon surgery, active inflammatory bowel disease, lower gastrointestinal bleeding
  • Therapeutic colonoscopy, proctosigmoidoscopy, bidirectional endoscopy
  • Inadequate consumption of bowel preparation
  • Known history of severe diverticulosis or diverticulitis
  • History of abdominal surgery previously requiring sedation for colonoscopy
  • Current narcotic/anxiolytic medication use
  • Prior unsuccessful experience with unsedation colonoscopy
  • Emergent colonoscopy

Outcomes

Primary Outcomes

Real-time maximum insertion pain(RTMIP) score

Time Frame: 2 hours

Pain during insertion reported to the unblinded assisting nursing, visual analogue scale (VAS): 0=no pain, 10=most severe pain. The highest pain score will be tabulated for analysis.Timing of data collection will be at the discretion of the nurse to minimize bias by colonoscopist behavior

Secondary Outcomes

  • Insertion time(2 hours)
  • Proximal colon ADR(2 hours)
  • Proportion with no insertion pain(2 hours)

Study Sites (2)

Loading locations...

Similar Trials